Duke University Investigational Drug Services — Durham, North Carolina

Duke University Investigational Drug Services is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Duke University Investigational Drug Services has participated in 1 clinical trials.

Therapeutic areas: Gram-negative Bacterial Infection.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Investigational Drug Services?

Duke University Investigational Drug Services has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Investigational Drug Services conducted?

Duke University Investigational Drug Services has 1 clinical trials on record. Their work covers Gram-negative Bacterial Infection.

Is Duke University Investigational Drug Services accredited by Crixeo Health?

Duke University Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.